Featured Sequencing Services
Explore our premium high-throughput sequencing technologies designed to fuel discoveries in modern clinical research and industrial biotechnology.
Whole Exome Sequencing in India: Market Dynamics & Research Growth
India is currently witnessing a massive transformation in its biotech and healthcare landscape. With a population exceeding 1.4 billion, the country offers a highly diverse genetic pool, rendering genomics and Next-Generation Sequencing (NGS) vital tools for medical progress. Among these technologies, Whole Exome Sequencing (WES) has emerged as the most practical, cost-effective, and clinically rich solution for identifying disease-causing genetic variants.
Did you know? While the exome constitutes only about 1% to 2% of the human genome, it contains approximately 85% of all known disease-causing mutations. This makes WES an incredibly efficient diagnostic tool for clinicians and researchers across India.
The genomics industry in India is thriving, anchored in key technology hubs such as Bengaluru, Hyderabad, Pune, and the Delhi-NCR region. Local academic institutions, research centers, and private diagnostics firms are actively using exome sequencing to unravel the genetic architecture of rare diseases, cancer, and metabolic disorders. The demand for accurate WES quotes in India has surged as healthcare setups aim to integrate genomic profiles into standard clinical workflows.
Key Drivers of WES Adoption in the Indian Context:
- Consanguinity & Rare Diseases: High rates of endogamous marriages in specific communities increase the risk of autosomal recessive disorders. WES provides a rapid route to diagnosis.
- Oncology Support: Identification of somatic mutations in cancer patients to guide targeted therapies and personalized medicine regimens.
- Government Initiatives: Programs like the GenomeIndia Project are raising awareness and creating a reference database of Indian genomes, accelerating local research.
About Biomarker Technologies (BMKGene)
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Our commitment to quality, high throughput, and advanced data analysis makes us a trusted global partner for research institutions, clinical organizations, and industrial clients seeking state-of-the-art sequencing services, including Whole Exome Sequencing.
Advanced Sequencing Platforms & Laboratory Capacity
To ensure high-quality sequencing data with rapid turnaround times, BMKGene utilizes a diverse array of industry-leading sequencing platforms. Our capabilities cover short-read sequencing, long-read sequencing, and advanced automation.
Our Platforms
PacBio platforms: Sequel II, Sequel, RSII
Nanopore platforms: PromethION P48, GridION X5 MinION
10X Genomics: 10X ChromiumX, 10X Chromium Controller
Illumina platforms: NovaSeq
BGI-sequencing platforms: DNBSEQ-G400, DNBSEQ-T7
Bionano Irys system, Waters XEVO G2-XS QTOF, QTRAP 6500+
20,000+ Sq. Ft. Facility
Our facility houses advanced biomolecular laboratory instruments and standard laboratories dedicated to sample extraction, library construction, clean rooms, and high-throughput sequencing.
All operations are conducted under strict SOPs to maintain the highest levels of quality control, ensuring consistent and reproducible results for every sample.
BMKCloud Platform
Our self-developed BMKCloud bioinformatics analysis platform features powerful computing capabilities to process massive datasets efficiently.
Equipped with CPUs featuring 41,104 memory, 3 PB total storage, and 4,260 computing cores with peak computing power over 121,708.8 Gflop per second.
Fully Automated NGS Library Construction
Brilliant Lab 1000 (BL1000)
Biomarker Technologies (BMKGENE) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to the high-throughput NGS library construction service.
By minimizing manual intervention, the BL1000 system ensures exceptional consistency, reduces human error, and dramatically increases throughput. BMKGENE strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide customers with better sequencing services worldwide, including the rapidly expanding Indian market.
Certified Quality
International standards for genomic operations
Understanding Whole Exome Sequencing Cost & Quotes in India
When researchers and clinicians in India look for Whole Exome Sequencing quotes, several factors influence the final pricing structure. Understanding these variables helps labs optimize their budgets and select the right platform configuration.
Key Factors Affecting WES Quotes:
- Sequencing Depth (Coverage): Clinical applications typically require 100x to 200x coverage to ensure high sensitivity for rare variants, whereas basic research projects might only require 50x or 100x coverage.
- Sample Type & Quality: High-quality genomic DNA extracted from fresh blood or tissue is easier to process than DNA extracted from FFPE (Formalin-Fixed Paraffin-Embedded) tissue blocks, which may require specialized library preparation.
- Data Analysis & Interpretation: Standard raw data delivery (FASTQ files) is more economical. Including advanced bioinformatics analysis (variant calling, annotation, clinical reporting) adds value and affects the quote.
- Turnaround Time (TAT): Fast-track or express sequencing services for critical clinical cases command a premium compared to standard turnaround times.
Localized WES Applications in India:
1. Clinical Diagnostics & Rare Diseases: With over 70 million rare disease patients in India, WES is crucial for establishing diagnostic answers in pediatric and genetic clinics.
2. Population Studies: Indian subpopulations possess unique genetic profiles. WES allows researchers to identify population-specific risk variants for diabetes, cardiovascular disorders, and drug responses (pharmacogenomics).
3. Agricultural Genomics: Beyond human health, exome capture techniques are applied to crop and livestock research to select traits for drought resistance and higher yields, supporting India's agricultural sector.
Enterprise Qualifications & Certifications
BMKGene maintains the highest standards of operational excellence, backed by globally recognized certifications, patents, and academic collaborations.
Complete Sequencing & Multi-Omics Product Catalog
We provide a comprehensive range of NGS and long-read sequencing services tailored to meet diverse research goals, from human genomics to environmental metagenomics.
For inquiries about our sequencing products, bioinformatics analysis, or custom project quotes, please leave your contact details. Our technical experts will get back to you within 24 hours.
Inquiry Now
